Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Nov 12;76(12):3175-3182.
doi: 10.1093/jac/dkab320.

Evaluation of the MYCOPLASMA IST3 urogenital mycoplasma assay in an international multicentre trial

Ian Boostrom  1 , Yohan Bala  2 , Jelena Minic Vasic  3 , Jelena Gluvakov  3 , Emmanuel Chanard  4 , Andrew H Barratt  1 , Kirsty Sands  1   5 , Edward Portal  1 , Laurence Devigne  6 , Lucy C Jones  1   7   8 , Owen B Spiller  1   9
Affiliations
Multicenter Study

Evaluation of the MYCOPLASMA IST3 urogenital mycoplasma assay in an international multicentre trial

Ian Boostrom et al. J Antimicrob Chemother. .

Abstract

Objectives: To evaluate the accuracy, susceptibility and specificity of MYCOPLASMA IST3, the next generation of the most popular culture-based in vitro diagnostic device designed to detect, identify and test the susceptibility of urogenital mycoplasma infections.

Methods: MYCOPLASMA IST3 was evaluated against culture- and molecular-based gold standard methodologies to detect, identify, enumerate and determine antimicrobial resistance for Mycoplasma hominis and Ureaplasma species in 516 clinical samples collected across France, Serbia and the UK. Sample types included vulvovaginal/endocervical or urethral swabs (dry swab or eSwab®), semen and urine samples, which included blinded analysis following addition of a panel of 80 characterized control strains.

Results: Overall species identification was excellent for both Ureaplasma spp. (98.4% sensitivity, 99.7% specificity) and M. hominis (95.7% sensitivity, 100% specificity) relative to combined colony morphology on agar and quantitative PCR standards. Non-dilution-based bacterial load estimation by the assay was accurate between 83.7% (M. hominis) and 86.3% (Ureaplasma spp.) of the time (increased to 94.2% and 100%, respectively, if ±10-fold variance was allowed) relative to colonies counted on agar. Resistance accuracy for Ureaplasma spp. varied from gold standards for only 11/605 of individual tests (major error rate = 1.8%) and for 14/917 individual tests for M. hominis (major error rate = 1.5%).

Conclusions: The redesigned MYCOPLASMA IST3 assay eliminated previous shortcomings by providing independent accurate resistance screening of M. hominis and Ureaplasma species, even in mixed infections, with CLSI-compliant thresholds. Specificity, sensitivity and enumeration estimates correlated closely with the confirmatory methods.

PubMed Disclaimer

References

    1. Dienes L, Edsall G.. Observations on the L-organism of Klieneberger. Proc Soc Exp Biol Med 1937; 36: 740–4.
    1. Shepard MC. The recovery of pleuropneumonia-like organisms from Negro men with and without nongonococcal urethritis. Am J Syph Gonorrhea Vener Dis 1954; 38: 113–24. - PubMed
    1. Shepard MC, Lunceford CD, Baker RL.. T-strain Mycoplasma: selective inhibition by erythromycin in vitro. Br J Vener Dis 1966; 42: 21–4. - PMC - PubMed
    1. Horner P, Donders G, Cusini M. et al. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? – a position statement from the European STI Guidelines Editorial Board. J Eur Acad Dermatol Venereol 2018; 32: 1845–51. - PubMed
    1. Plummer EL, Vodstrcil LA, Bodiyabadu K. et al. Are Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasmaparvum associated with specific genital symptoms and clinical signs in non-pregnant women? Clin Infect Dis 2021; ciab061. - PubMed

Publication types